细胞癌-话题@MedSci

#细胞癌#

1086篇内容 | 2644人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1979372, encodeId=2f1f19e937205, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=BMC Ophthalmol：眼周基底细胞癌的5年观察结果, objectType=article, longId=738412, objectId=eb74e3841281, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=eb74e3841281, replyNumber=0, likeNumber=81, createdTime=2022-09-11, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=eb74e3841281, moduleTitle=BMC Ophthalmol：眼周基底细胞癌的5年观察结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=eb74e3841281)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979305, encodeId=81f619e9305b2, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=Lancet Oncol：NAFLD相关肝细胞癌的临床特征及预后, objectType=article, longId=300612, objectId=96c030061203, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=96c030061203, replyNumber=0, likeNumber=101, createdTime=2022-06-07, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=96c030061203, moduleTitle=Lancet Oncol：NAFLD相关肝细胞癌的临床特征及预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=96c030061203)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979335, encodeId=e25d19e9335e4, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=JEADV：刮除术与冷冻手术治疗浅表性基底细胞癌的比较研究, objectType=article, longId=727187, objectId=b899e2718712, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b899e2718712, replyNumber=0, likeNumber=77, createdTime=2022-10-05, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b899e2718712, moduleTitle=JEADV：刮除术与冷冻手术治疗浅表性基底细胞癌的比较研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b899e2718712)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979340, encodeId=810219e934067, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=ASCO 2022 | 肝细胞癌患者肝移植后 30 天再入院率的预测因素, objectType=article, longId=728445, objectId=f96ae28445fc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f96ae28445fc, replyNumber=0, likeNumber=74, createdTime=2023-04-12, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f96ae28445fc, moduleTitle=ASCO 2022 | 肝细胞癌患者肝移植后 30 天再入院率的预测因素, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f96ae28445fc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979301, encodeId=8e0019e93017e, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=Clin Cancer Res：帕博利珠单抗新辅助和辅助治疗可切除局部晚期头颈部鳞状细胞癌患者的疗效, objectType=article, longId=300287, objectId=836930028e24, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=836930028e24, replyNumber=0, likeNumber=99, createdTime=2023-01-20, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=836930028e24, moduleTitle=Clin Cancer Res：帕博利珠单抗新辅助和辅助治疗可切除局部晚期头颈部鳞状细胞癌患者的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=836930028e24)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979298, encodeId=51e619e9298e1, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=Oncologist：Toripalimab（特瑞普利单抗）联合紫杉醇+卡铂新辅助治疗可切除局部晚期食管鳞状细胞癌的疗效, objectType=article, longId=299451, objectId=fc31299451e9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fc31299451e9, replyNumber=0, likeNumber=83, createdTime=2022-04-07, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fc31299451e9, moduleTitle=Oncologist：Toripalimab（特瑞普利单抗）联合紫杉醇+卡铂新辅助治疗可切除局部晚期食管鳞状细胞癌的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fc31299451e9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979311, encodeId=910a19e93117b, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=Front Oncol：早期子宫内膜透明细胞癌患者行系统淋巴结切除术可改善患者预后, objectType=article, longId=301740, objectId=1ac9301e4007, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1ac9301e4007, replyNumber=0, likeNumber=85, createdTime=2022-11-17, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1ac9301e4007, moduleTitle=Front Oncol：早期子宫内膜透明细胞癌患者行系统淋巴结切除术可改善患者预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1ac9301e4007)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979336, encodeId=93ea19e9336db, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=Cancers：肝细胞癌根治术后使用直接作用的抗病毒药物清除丙型肝炎病毒可以抑制癌症复发, objectType=article, longId=727864, objectId=1029e2786484, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1029e2786484, replyNumber=0, likeNumber=94, createdTime=2022-12-20, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1029e2786484, moduleTitle=Cancers：肝细胞癌根治术后使用直接作用的抗病毒药物清除丙型肝炎病毒可以抑制癌症复发, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1029e2786484)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979320, encodeId=a1e619e9320d2, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=Lancet Oncol：转移性肾透明细胞癌的三种一线治疗方案的疗效和安全性, objectType=article, longId=723824, objectId=cc6fe23824f3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cc6fe23824f3, replyNumber=0, likeNumber=99, createdTime=2022-10-12, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cc6fe23824f3, moduleTitle=Lancet Oncol：转移性肾透明细胞癌的三种一线治疗方案的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cc6fe23824f3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979292, encodeId=034119e92929e, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=AP&T: 血清生长分化因子15可以预测丙型肝炎患者病毒消除后肝细胞癌的发生, objectType=article, longId=295535, objectId=e0af295535bd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e0af295535bd, replyNumber=0, likeNumber=108, createdTime=2022-11-03, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e0af295535bd, moduleTitle=AP&T: 血清生长分化因子15可以预测丙型肝炎患者病毒消除后肝细胞癌的发生, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e0af295535bd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979328, encodeId=9d6a19e932824, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=Clin Cancer Res：甲胎蛋白可作为肝细胞癌采用Atezolizuma+贝伐单抗治疗的预后生物标志物, objectType=article, longId=726091, objectId=2391e260910b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2391e260910b, replyNumber=0, likeNumber=111, createdTime=2022-11-09, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2391e260910b, moduleTitle=Clin Cancer Res：甲胎蛋白可作为肝细胞癌采用Atezolizuma+贝伐单抗治疗的预后生物标志物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2391e260910b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979286, encodeId=fd6819e928674, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=NEJM：纳武单抗联合治疗对晚期食管鳞状细胞癌的疗效分析, objectType=article, longId=295127, objectId=119b29512e22, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=119b29512e22, replyNumber=0, likeNumber=78, createdTime=2022-04-30, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=119b29512e22, moduleTitle=NEJM：纳武单抗联合治疗对晚期食管鳞状细胞癌的疗效分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=119b29512e22)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979321, encodeId=f5e319e932120, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=Eur Urol：评估两种起始剂量的乐伐替尼加依维莫司对肾细胞癌患者的安全性和有效性：一项随机的2期试验, objectType=article, longId=723858, objectId=379fe238584a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=379fe238584a, replyNumber=0, likeNumber=92, createdTime=2022-09-10, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=379fe238584a, moduleTitle=Eur Urol：评估两种起始剂量的乐伐替尼加依维莫司对肾细胞癌患者的安全性和有效性：一项随机的2期试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=379fe238584a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979367, encodeId=f81219e9367f4, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=Eur Urol：Pembrolizumab+Axitinib与Sunitinib治疗晚期肾细胞癌的生活质量比较, objectType=article, longId=736966, objectId=ac21e36966ab, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ac21e36966ab, replyNumber=0, likeNumber=72, createdTime=2023-07-27, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ac21e36966ab, moduleTitle=Eur Urol：Pembrolizumab+Axitinib与Sunitinib治疗晚期肾细胞癌的生活质量比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ac21e36966ab)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979357, encodeId=82c319e935712, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=European Radiology：这些MRI征象为晚期肝内胆管细胞癌患者提供个性化服务！, objectType=article, longId=734128, objectId=17a5e34128ce, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=17a5e34128ce, replyNumber=0, likeNumber=66, createdTime=2022-09-04, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=17a5e34128ce, moduleTitle=European Radiology：这些MRI征象为晚期肝内胆管细胞癌患者提供个性化服务！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=17a5e34128ce)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979348, encodeId=238f19e93487d, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=Clin Cancer Res：MEDI0680联合杜瓦鲁单抗治疗晚期肾透明细胞癌, objectType=article, longId=729652, objectId=3bf0e296528c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3bf0e296528c, replyNumber=0, likeNumber=82, createdTime=2023-02-28, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3bf0e296528c, moduleTitle=Clin Cancer Res：MEDI0680联合杜瓦鲁单抗治疗晚期肾透明细胞癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3bf0e296528c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979294, encodeId=d9d719e929462, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=CGH: 非酒精性脂肪肝患者使用他汀类药物可以降低肝细胞癌的风险, objectType=article, longId=299169, objectId=8e1b29916963, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8e1b29916963, replyNumber=0, likeNumber=86, createdTime=2022-08-01, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8e1b29916963, moduleTitle=CGH: 非酒精性脂肪肝患者使用他汀类药物可以降低肝细胞癌的风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8e1b29916963)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979279, encodeId=523119e9279dd, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=Cancers：多中心研究探索局部晚期 Merkel细胞癌的治疗、预后以及相关因素, objectType=article, longId=294336, objectId=919e2943363f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=919e2943363f, replyNumber=0, likeNumber=65, createdTime=2022-01-21, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=919e2943363f, moduleTitle=Cancers：多中心研究探索局部晚期 Merkel细胞癌的治疗、预后以及相关因素, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=919e2943363f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979331, encodeId=920719e933136, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=CGH:恶病质在肝细胞癌患者中普遍存在并与更差的预后相关, objectType=article, longId=726393, objectId=1de8e26393ac, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1de8e26393ac, replyNumber=0, likeNumber=83, createdTime=2022-07-12, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1de8e26393ac, moduleTitle=CGH:恶病质在肝细胞癌患者中普遍存在并与更差的预后相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1de8e26393ac)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979322, encodeId=2fa119e932245, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=皮肤鳞状细胞癌，什么时候该切？什么时候不该切？Is a question., objectType=article, longId=724307, objectId=7613e243076b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7613e243076b, replyNumber=0, likeNumber=85, createdTime=2022-11-15, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7613e243076b, moduleTitle=皮肤鳞状细胞癌，什么时候该切？什么时候不该切？Is a question., moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7613e243076b)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

细胞癌

2020-05-29

qingting (审核中...)

前往app查看评论内容

#细胞癌#

BMC Ophthalmol：眼周基底细胞癌的5年观察结果

2022-09-11

qingting (审核中...)

前往app查看评论内容

#细胞癌#

Lancet Oncol：NAFLD相关肝细胞癌的临床特征及预后

2022-06-07

qingting (审核中...)

前往app查看评论内容

#细胞癌#

JEADV：刮除术与冷冻手术治疗浅表性基底细胞癌的比较研究

2022-10-05

qingting (审核中...)

前往app查看评论内容

#细胞癌#

ASCO 2022 | 肝细胞癌患者肝移植后 30 天再入院率的预测因素

2023-04-12

qingting (审核中...)

前往app查看评论内容

#细胞癌#

Clin Cancer Res：帕博利珠单抗新辅助和辅助治疗可切除局部晚期头颈部鳞状细胞癌患者的疗效

2023-01-20

qingting (审核中...)

前往app查看评论内容

#细胞癌#

Oncologist：Toripalimab（特瑞普利单抗）联合紫杉醇+卡铂新辅助治疗可切除局部晚期食管鳞状细胞癌的疗效

2022-04-07

qingting (审核中...)

前往app查看评论内容

#细胞癌#

Front Oncol：早期子宫内膜透明细胞癌患者行系统淋巴结切除术可改善患者预后

2022-11-17

qingting (审核中...)

前往app查看评论内容

#细胞癌#

Cancers：肝细胞癌根治术后使用直接作用的抗病毒药物清除丙型肝炎病毒可以抑制癌症复发

2022-12-20

qingting (审核中...)

前往app查看评论内容

#细胞癌#

Lancet Oncol：转移性肾透明细胞癌的三种一线治疗方案的疗效和安全性

2022-10-12

qingting (审核中...)

前往app查看评论内容

#细胞癌#

AP&T: 血清生长分化因子15可以预测丙型肝炎患者病毒消除后肝细胞癌的发生

2022-11-03

qingting (审核中...)

前往app查看评论内容

#细胞癌#

Clin Cancer Res：甲胎蛋白可作为肝细胞癌采用Atezolizuma+贝伐单抗治疗的预后生物标志物

2022-11-09

qingting (审核中...)

前往app查看评论内容

#细胞癌#

NEJM：纳武单抗联合治疗对晚期食管鳞状细胞癌的疗效分析

2022-04-30

qingting (审核中...)

前往app查看评论内容

#细胞癌#

Eur Urol：评估两种起始剂量的乐伐替尼加依维莫司对肾细胞癌患者的安全性和有效性：一项随机的2期试验

2022-09-10

qingting (审核中...)

前往app查看评论内容

#细胞癌#

Eur Urol：Pembrolizumab+Axitinib与Sunitinib治疗晚期肾细胞癌的生活质量比较

2023-07-27

qingting (审核中...)

前往app查看评论内容

#细胞癌#

European Radiology：这些MRI征象为晚期肝内胆管细胞癌患者提供个性化服务！

2022-09-04

qingting (审核中...)

前往app查看评论内容

#细胞癌#

Clin Cancer Res：MEDI0680联合杜瓦鲁单抗治疗晚期肾透明细胞癌

2023-02-28

qingting (审核中...)

前往app查看评论内容

#细胞癌#

CGH: 非酒精性脂肪肝患者使用他汀类药物可以降低肝细胞癌的风险

2022-08-01

qingting (审核中...)

前往app查看评论内容

#细胞癌#

Cancers：多中心研究探索局部晚期 Merkel细胞癌的治疗、预后以及相关因素

2022-01-21

qingting (审核中...)

前往app查看评论内容

#细胞癌#

CGH:恶病质在肝细胞癌患者中普遍存在并与更差的预后相关

2022-07-12

qingting (审核中...)

前往app查看评论内容

#细胞癌#

皮肤鳞状细胞癌，什么时候该切？什么时候不该切？Is a question.

2022-11-15

科室
- - 订阅+
  - 更多科室
工具
服务